![]() | |
Clinical data | |
---|---|
Other names | 16α-Ethylthiodydrogesterone; 16α-Ethylthio-6-dehydroretroprogesterone; 16α-Ethylthio-9β,10α-pregna-4,6-diene-3,20-dione |
Routes of administration | Oral |
Identifiers | |
| |
CAS Number | |
ChemSpider | |
Chemical and physical data | |
Formula | C23H32O2S |
Molar mass | 372.57 g·mol−1 |
3D model (JSmol) | |
| |
|
Ro 6-3129, also known as 16α-ethylthio-6-dehydroretroprogesterone or as 16α-ethylthio-9β,10α-pregna-4,6-diene-3,20-dione, as well as 16α-ethylthiodydrogesterone, is a progestogen of the retroprogesterone group which was developed by Roche but was never marketed.[1][2][3] It shows greater potency than dydrogesteroneinbioassays.[4]
![]() | This article about a steroid is a stub. You can help Wikipedia by expanding it. |
![]() | This drug article relating to the genito-urinary system is a stub. You can help Wikipedia by expanding it. |